Kenvue Inc. logo
KVUEKenvue Inc.

Average Return on Equity (ROE)

Return on Equity (ROE)

The latest reported return on equity (roe) is 13.66% as of Sunday, December 28, 2025, shown against its trailing averages.

KVUE Return on Equity (ROE)

KVUE Average Return on Equity (ROE)

KVUE Return on Equity (ROE) Averages

RETURN ON EQUITY (ROE) LATEST REPORTED

13.66%

RETURN ON EQUITY (ROE) TTM

12.16%

RETURN ON EQUITY (ROE) 3Y

12.37%

RETURN ON EQUITY (ROE) 5Y

9.15%

RETURN ON EQUITY (ROE) 10Y

N/A

RETURN ON EQUITY (ROE) 15Y

N/A

RETURN ON EQUITY (ROE) 20Y

N/A

About Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Summit, NJ
22,000 employees
Consumer Defensive / Household & Personal Products
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Kirk L. Perry